IP Library Granted Patent US 12,727,796
Granted Patent B2
US 12,727,796 · App. 17/085,392 · Granted Sep 8, 2026

Tissue oxygen saturation detection and related apparatus and methods

Inventors: Daniel Wiese (Cambridge, MA); Pamela G. Anderson (Boston, MA); Alessandro Babini (Cambridge, MA)
Assignee: Whoop, Inc.
A61B5/14551A61B5/0017A61B5/6802A61B5/6831A61B2562/0238A61B2562/043A61B2562/164
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,727,796
App. No.
17/085,392
Granted
Sep 8, 2026
Kind
B2
Abstract

A wearable optical device is described for optically detecting parameters of interest within muscle, such as during physical activity or when at rest. The parameters of interest include oxygenation level and/or hemoglobin concentrations in some situations. The detected parameters, such as oxygenation level, may be used to assess physical performance, such as the extent to which the muscle is utilizing aerobic or anaerobic processes. Methods for determining the parameters of interest, such as oxygenation level, from the detected optical signals are also described, and feedback may be provided to a user.

Claims (29)

1 . A system for optical measurement of oxygenation, the system comprising:

a wearable housing;

an optical source array in the wearable housing including a plurality of optical sources;

a plurality of optical detectors in the wearable housing, the plurality of optical sources and the plurality of optical detectors arranged in three or more source-detector pairs formed between at least two optical sources and at least two optical detectors, wherein:

the plurality of optical detectors and optical sources are arranged into two or more zones,

each of the two or more zones includes at least one pair of the optical sources or at least one pair of the optical detectors,

the two or more zones are arranged in a line spanning a surface above a volume of tissue, and

the optical detectors and the optical sources are arranged within the two or more zones such that none of the two or more zones include both an optical source and an optical detector and one or more source-detector pairs between two of the two or more zones are at different distances than one or more other source-detector pairs between the two of the two or more zones, and

each source-detector pair spanning the two or more zones probes a same volume of tissue spanned by the line between the two or more zones; and

a processor configured to convert optical signals from the plurality of optical detectors into an indication of oxygenation or hemoglobin concentration including one or more of muscle oxygenation (SmO 2 ), oxygenated hemoglobin concentration (HbO 2 ), deoxygenated hemoglobin concentration (Hb), or total hemoglobin concentration (HbT), wherein the processor is configured to apply a plurality of curve fitting procedures to a plurality of alternative combinations of the plurality of optical sources and the plurality of optical detectors to obtain depth-dependent information about the indication of oxygenation or hemoglobin concentration in inhomogeneous tissue having different optical properties at different depths.

2 . The system of claim 1 , wherein the plurality of optical detectors include at least a second optical detector larger than a first optical detector.

3 . The system of claim 1 , wherein the plurality of optical sources includes certain optical sources arranged substantially linearly with respect to one another.

4 . The system of claim 1 , wherein the plurality of optical detectors includes certain optical detectors arranged substantially linearly with respect to one another.

5 . The system of claim 1 , wherein the processor is disposed within the wearable housing and is coupled to outputs of the plurality of optical detectors.

6 . The system of claim 1 , further comprising an adjustable strap affixed to the wearable housing.

7 . The system of claim 1 , wherein the processor is configured to convert optical signals from the plurality of optical detectors into an indication of muscle oxygenation.

8 . The system of claim 1 , wherein the processor is configured to convert optical signals from the plurality of optical detectors into an indication of total hemoglobin concentration.

9 . The system of claim 1 , wherein the processor is configured to convert optical signals from the plurality of optical detectors into an indication of deoxygenated hemoglobin concentration.

10 . The system of claim 1 , further comprising a coil disposed on or within the wearable housing, the coil configured to receive a wireless charging signal.

11 . The system of claim 1 , further comprising wireless communication circuitry configured to wirelessly transmit data indicative of signals produced by the plurality of optical detectors.

12 . The system of claim 1 , wherein the wearable housing includes a recess in which the optical source array is disposed such that the optical source array lies beneath a surface of the wearable housing.

13 . The system of claim 1 , wherein the wearable housing includes a recess in which the plurality of optical detectors are disposed such that the plurality of optical detectors lie beneath a surface of the wearable housing.

14 . The system of claim 1 , wherein the plurality of optical sources includes certain optical sources arranged non-linearly with respect to one another.

15 . The system of claim 1 , wherein the plurality of optical detectors includes certain optical detectors arranged non-linearly with respect to one another.

16 . The system of claim 1 , wherein the plurality of optical sources include a plurality of LEDs.

17 . The system of claim 1 , wherein the plurality of optical sources emit light signals with at least two peak wavelengths in the red-to-infrared spectrum.

18 . The system of claim 1 , wherein the plurality of optical sources emit light signals with at least two peak wavelengths of 660 nanometers and 855 nanometers.

19 . The system of claim 1 , wherein the inhomogeneous tissue includes adipose tissue located superficially to muscle.

20 . The system of claim 1 , wherein the depth dependent information includes a measurement of superficial fat content in the tissue.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Sep 13, 2024
From: FIRST-CITIZENS BANK & TRUST COMPANY
To: WHOOP, INC.
Reel/Frame 068968/0475 →
RELEASE OF SECURITY INTEREST Recorded Aug 15, 2024
From: FIRST-CITIZENS BANK & TRUST COMPANY
To: WHOOP, INC.
Reel/Frame 068656/0900 →
RELEASE OF SECURITY INTEREST Recorded Jul 30, 2024
From: TRINITY CAPITAL INC.
To: WHOOP, INC.
Reel/Frame 068235/0850 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 29, 2024
From: WHOOP, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 068179/0287 →
ADDRESS CHANGE Recorded Oct 31, 2023
From: WHOOP, INC.
To: WHOOP, INC.
Reel/Frame 065413/0356 →
SECURITY INTEREST Recorded May 18, 2023
From: WHOOP, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 063697/0550 →
SECOND AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 18, 2023
From: WHOOP, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY (SUCCESSOR BY PURCHASE TO THE FEDERAL DEPOSIT INSURANCE CORPORATION AS RECEIVER FOR SILICON VALLEY BRIDGE BANK, N.A. (AS SUCCESSOR TO SILICON VALLEY BANK))
Reel/Frame 063696/0075 →
SECURITY INTEREST Recorded Sep 6, 2022
From: WHOOP, INC.
To: SILICON VALLEY BANK
Reel/Frame 061386/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2021
From: ABC123 WIND DOWN, INC.
To: WHOOP, INC.
Reel/Frame 055620/0262 →
CHANGE OF NAME Recorded Mar 9, 2021
From: DYNOMETRICS INC. D/B/A HUMON
To: ABC123 WIND DOWN, INC.
Reel/Frame 055531/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2021
From: WIESE, DANIEL; ANDERSON, PAMELA G.; BABINI, ALESSANDRO
To: DYNOMETRICS INC. D/B/A HUMON
Reel/Frame 055443/0315 →
Continuity (3)
Continuation PCTUS2019029865 · Apr 30, 2019
Provisional Application 62665455 · May 1, 2018
Related Publication 20210045671A1 · Feb 18, 2021
References Cited (134)
US 6587703B2 · Cheng et al. · 2003 [cited by applicant]
US 6678541B1 · Durkin · 2004 [cited by applicant]
US 7047056B2 · Hannula et al. · 2006 [cited by applicant]
US 7460897B1 · Flessland et al. · 2008 [cited by applicant]
US 7532919B2 · Soyemi et al. · 2009 [cited by applicant]
US RE41317E · Parker · 2010 [cited by applicant]
US 7884933B1 · Kashyap · 2011 [cited by examiner]
US 8527028B2 · Kurzweil et al. · 2013 [cited by applicant]
US 8668187B2 · Al-Anzi · 2014 [cited by applicant]
US 8688187B2 · Dellostritto et al. · 2014 [cited by applicant]
US 8929967B2 · Mao et al. · 2015 [cited by applicant]
US 8941830B2 · Schmitz · 2015 [cited by applicant]
US 8996088B2 · Dasco et al. · 2015 [cited by applicant]
US 9095291B2 · Soller et al. · 2015 [cited by applicant]
US 9277867B2 · Kurzweil et al. · 2016 [cited by applicant]
US 9591999B2 · Schenkman · 2017 [cited by applicant]
US 10092228B2 · Wiese et al. · 2018 [cited by applicant]
US 10799162B2 · Wiese et al. · 2020 [cited by applicant]
US 10925327B2 · Cobbett et al. · 2021 [cited by applicant]
US 20020026106A1 · Khalil et al. · 2002 [cited by applicant]
US 20020188210A1 · Aizawa · 2002 [cited by applicant]
US 20030225323A1 · Kiani · 2003 [cited by examiner]
US 20080097173A1 · Soyemi et al. · 2008 [cited by applicant]
US 20080208011A1 · Shuler · 2008 [cited by applicant]
US 20080269644A1 · Ray · 2008 [cited by applicant]
US 20090105555A1 · Dasco et al. · 2009 [cited by applicant]
US 20090112071A1 · LeBoeuf et al. · 2009 [cited by applicant]
US 20090234206A1 · Gaspard et al. · 2009 [cited by applicant]
US 20100238636A1 · Mascaro et al. · 2010 [cited by applicant]
US 20110205535A1 · Soller · 2011 [cited by examiner]
US 20120053431A1 · Mannheimer et al. · 2012 [cited by applicant]
US 20120197093A1 · LeBoeuf et al. · 2012 [cited by applicant]
US 20120246795A1 · Scheffler et al. · 2012 [cited by applicant]
US 20130096403A1 · Dasco et al. · 2013 [cited by applicant]
US 20130119255A1 · Dickinson et al. · 2013 [cited by applicant]
US 20130144330A1 · Mcewen et al. · 2013 [cited by applicant]
US 20130158372A1 · Haisley · 2013 [cited by examiner]
US 20130211208A1 · Varadan et al. · 2013 [cited by applicant]
US 20130274611A1 · Silveira et al. · 2013 [cited by applicant]
US 20140107493A1 · Yuen et al. · 2014 [cited by applicant]
US 20140139637A1 · Mistry et al. · 2014 [cited by applicant]
US 20140275852A1 · Hong et al. · 2014 [cited by applicant]
US 20140343383A1 · Sato · 2014 [cited by applicant]
US 20150011850A1 · Ruchti · 2015 [cited by examiner]
US 20150040282A1 · Longinotti-buitoni et al. · 2015 [cited by applicant]
US 20150051500A1 · Elliott et al. · 2015 [cited by applicant]
US 20150148624A1 · Benaron · 2015 [cited by applicant]
US 20150182164A1 · Utter, II · 2015 [cited by applicant]
US 20150196238A1 · Dasco et al. · 2015 [cited by applicant]
US 20150201853A1 · Hong et al. · 2015 [cited by applicant]
US 20150230743A1 · Silveira et al. · 2015 [cited by applicant]
US 20150335284A1 · Nuovo et al. · 2015 [cited by applicant]
US 20150342529A1 · Gassoway et al. · 2015 [cited by applicant]
US 20160022157A1 · Melker et al. · 2016 [cited by applicant]
US 20160038055A1 · Wheeler · 2016 [cited by examiner]
US 20160052444A1 · Vorhies et al. · 2016 [cited by applicant]
US 20160058381A1 · Lee et al. · 2016 [cited by applicant]
US 20160278642A1 · Vogel et al. · 2016 [cited by applicant]
US 20170000415A1 · Lapetina · 2017 [cited by examiner]
US 20170049417A1 · Liu et al. · 2017 [cited by applicant]
US 20170127958A1 · Ungureanu et al. · 2017 [cited by applicant]
US 20170135633A1 · Connor · 2017 [cited by applicant]
US 20170273576A1 · Ozawa · 2017 [cited by examiner]
US 20170281087A1 · Workman et al. · 2017 [cited by applicant]
US 20170303837A1 · Bechtel · 2017 [cited by examiner]
US 20170332980A1 · Fifield et al. · 2017 [cited by applicant]
US 20180132766A1 · Lee · 2018 [cited by examiner]
US 20180249937A1 · Wiese et al. · 2018 [cited by applicant]
US 20190099116A1 · Wiese et al. · 2019 [cited by applicant]
US 20190298987A1 · Freeman et al. · 2019 [cited by applicant]
US 20200352487A1 · Ray et al. · 2020 [cited by applicant]
US 20210045671A1 · Wiese et al. · 2021 [cited by applicant]
US 20210196975A1 · De Taboada et al. · 2021 [cited by applicant]
CN 103610467 · 2014 [cited by applicant]
JP H05192316A · 1993 [cited by applicant]
JP H06319723A · 1994 [cited by applicant]
KR 20160102925 · 2016 [cited by applicant]
KR 1020170124943 · 2017 [cited by applicant]
WO WO98023916A1 · 1998 [cited by applicant]
WO WO2013023071A1 · 2013 [cited by applicant]
WO WO2015122980 · 2015 [cited by applicant]
WO WO2015200380 · 2015 [cited by applicant]
WO WO2016025851A1 · 2016 [cited by applicant]
WO WO2016023027 · 2016 [cited by applicant]
WO WO2017151856A1 · 2017 [cited by applicant]
WO WO2017156022 · 2017 [cited by applicant]
EPO, “EP Application No. 17760772.8 Decision to Refuse mailed Nov. 14, 2022” , 11 pages. [cited by applicant]
EPO, “EP Application No. 22185197.5 Extended Search Report mailed Jan. 17, 2023”, 11 pages. [cited by applicant]
EPO, “EP Application No. 22186002.6 Extended Search Report mailed Oct. 17, 2022”, 8 pages. [cited by applicant]
AUSPAT, “AU Application No. 2017226296, Examination Report dated Mar. 29, 2021,”, 6 pages. [cited by applicant]
EPO, “EP Application No. 17760772.8, Examination Report dated Apr. 28, 2021”, 6 pages. [cited by applicant]
EPO, “EP Application No. 17760772.8, Summons to Attend Oral Proceedings dated Mar. 15, 2022”, 6 pages. [cited by applicant]
EPO, “EP Application No. 19795943.0, Extended Search Report dated Dec. 10, 2021”, 4 pages. [cited by applicant]
EPO, “EP Application No. 19796119.6, Extended Search Report dated Dec. 13, 2021”, 7 pages. [cited by applicant]
EPO, “EP Application No. 19797008.0, Extended Search Report dated Dec. 23, 2021”, 7 pages. [cited by applicant]
JPO, “JP Application No. 2018-565252 Office Action dated Nov. 19, 2019”, English and Japanese Translations , 10 pages. [cited by applicant]
WIPO, “PCT Application No. PCT/US19/29913, International Preliminary Report on Patentability dated Nov. 12, 2020”, 6 pages. [cited by applicant]
ISA/US, “PCT Application No. PCT/US19/29913, International Search Report and Written Opinion dated Jul. 3, 2019”, 7 pages. [cited by applicant]
WIPO, “PCT Application No. PCT/US19/29963, International Preliminary Report on Patentability dated Nov. 12, 2020”, 7 pages. [cited by applicant]
ISA/US, “PCT Application No. PCT/US19/29963, International Search Report and Written Opinion dated Jul. 2, 2019”, 9 pages. [cited by applicant]
USPTO, “U.S. Appl. No. 15/971,870, Notice of Allowance dated Jul. 24, 2018”, 12 pages. [cited by applicant]
USPTO, “U.S. Appl. No. 16/118,845, Non-Final Office Action mailed Nov. 29, 2019”, 7 pages. [cited by applicant]
USPTO, “U.S. Appl. No. 16/118,845, Notice of Allowance mailed Jun. 12, 2020”, 5 pages. [cited by applicant]
International Search Report and Written Opinion mailed Jul. 2, 2019 in connection with International Application No. PCT/US2019/029865. [cited by applicant]
International Search Report and Written Opinion mailed May 16, 2017 in connection with International Application No. PCT/US2017/020348. [cited by applicant]
International Preliminary Report on Patentability mailed Mar. 30, 2018 in connection with International Application No. PCT/US2017/020348. [cited by applicant]
Extended European Search Report dated Jul. 15, 2019 in connection with European Application No. 17760772.8. [cited by applicant]
European Communication dated Apr. 15, 2020 in connection with European Application No. 17760772.8. [cited by applicant]
Asada et al., Wearable sensors for human health monitoring. Smart Structures and Materials. Proceedings of SPIE. Mar. 16, 2006; 6174:617401-1. [cited by applicant]
Cubeddu et al., Compact tissue oximeter based on dual-wavelength multichannel time-resolved reflectance. Applied Optics. Jun. 1, 1999; 38(16):3670-3680. [cited by applicant]
USPTO, “U.S. Appl. No. 17/085,464 Non-Final Office Action mailed Sep. 15, 2023”, 17 pages. [cited by applicant]
USPTO, “U.S. Appl. No. 17/086,182 Non-Final Office Action mailed Sep. 13, 2023”, 12 pages. [cited by applicant]
International Preliminary Report on Patentability mailed Nov. 12, 2020 in connection with International Application No. PCT/US2019/029865. [cited by applicant]
USPTO, “U.S. Appl. No. 17/085,464 Final Office Action mailed Apr. 26, 2024”, 19 pages. [cited by applicant]
USPTO, “U.S. Appl. No. 17/086,182 Final Office Action mailed Apr. 24, 2024”, 15 pages. [cited by applicant]
EPO, , “EP Application No. 22186002.6 Communication Pursuant to Article 94(3) mailed Oct. 21, 2024”, 8 pages. [cited by applicant]
USPTO, , “U.S. Appl. No. 17/085,464 Non-Final Office Action mailed Oct. 21, 2024”, 36 pages. [cited by applicant]
USPTO, , “U.S. Appl. No. 17/086,182 Non-Final Office Action mailed Oct. 23, 2024”, 15 pages. [cited by applicant]
NASA, , “Synchronous Photodiode-Signal Sampler”, NASA Tech Brief, accessed at https://ntrs.nasa.gov/citations/19880000320 Jun. 1, 1988 , 1 page. [cited by applicant]
USPTO, , “U.S. Appl. No. 17/085,464 Final Office Action mailed Apr. 14, 2025”, 37 pages. [cited by applicant]
USPTO, , “U.S. Appl. No. 17/086,182 Final Office Action mailed May 20, 2025”, 17 pages. [cited by applicant]
EPO, , “EP Application No. 22186002.6 Communication Pursuant to Article 94(3) mailed Jun. 3, 2025”, 4 pages. [cited by applicant]
USPTO, , “U.S. Appl. No. 17/085,464 Final Office Action mailed Nov. 3, 2025”, 24 pages. [cited by applicant]
EPO, , “EP Application No. 19797008.0 Communication Pursuant to Article 94(3) mailed Jan. 21, 2026”, , 8 pages. [cited by applicant]
USPTO, , “U.S. Appl. No. 17/086,182 Notice of Allowance mailed Dec. 9, 2025”, , 9 pages. [cited by applicant]
PCT/US2019/029865, Nov. 12, 2020, International Preliminary Report on Patentability. [cited by applicant]
EPO, , “EP Application No. 19797008.0 Communication Pursuant to Article 94(3) mailed Dec. 18, 2023”, , 6 pages. [cited by applicant]
PCT/US2019/029865, Jul. 2, 2019, International Search Report and Written Opinion. [cited by applicant]
PCT/US2017/020348, May 16, 2017, International Search Report and Written Opinion. [cited by applicant]
PCT/US2017/020348, Mar. 30, 2018, International Preliminary Report on Patentability. [cited by applicant]
EP 17760772.8, Jul. 15, 2019, Extended European Search Report. [cited by applicant]
EP 17760772.8, Apr. 15, 2020, European Communication. [cited by applicant]
IP Australia, “AU Application Serial No. 2019263044 Examination Report mailed Feb. 19, 2024”, 3 pages. [cited by applicant]
IP Australia, “AU Application Serial No. 2019263069 Examination Report mailed Feb. 12, 2024”, 3 pages. [cited by applicant]